7th Translational Research E-Conference
Myelodysplastic Syndromes
Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres

7th Translational Research E-Conference
Myelodysplastic Syndromes
Information
ABOUT THE CONFERENCE:
Until recently, information on the biology of MDS and options available for its treatment were limited. A lot of data has accumulated in recent years on the pathophysiology of MDS, particularly on the role of somatic mutations (including in very early disease phase), haploinsufficiency for certain genes, and the impact of abnormalities of the microenvironment. Prognostic factors of the disease have also been refined, with the revised IPSS, and new factors like somatic mutations. Treatment approaches are improving, although not at the same speed, and only allogeneic stem cell transplantation remains potentially curative.The 7th ESH Conference on MDS is designed to provide time and multiple opportunities for critical discussion and informal scientific interaction with internationally recognized experts in the field.


